UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029578
Receipt number R000033792
Scientific Title Effects of beverage containing citrate on blood lactate concentration after exercise
Date of disclosure of the study information 2017/10/16
Last modified on 2019/04/18 15:02:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of beverage containing citrate on blood lactate concentration after exercise

Acronym

Effect of citrate on blood lactate after exercise

Scientific Title

Effects of beverage containing citrate on blood lactate concentration after exercise

Scientific Title:Acronym

Effect of citrate on blood lactate after exercise

Region

Japan


Condition

Condition

Adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effect of post-exercise citrate ingestion on blood lactate concentration.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Blood lactate concentration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Post-exercise ingestion of beverage containing citrate, single administration

Interventions/Control_2

Post-exercise ingestion of beverage without citrate, single administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >=

Gender

Male

Key inclusion criteria

Healthy subject

Key exclusion criteria

1) Subjects receiving treatment (medicine prescription by a doctor)
2) Subjects suffering from serious cardiovascular disorder, liver function disorder, renal dysfunction, respiratory disorder, endocrine disorder, metabolic disorder, or those having history of them
3) Subjects with history of chest pain or fainting.
4) Subjects who are likely to cause allergies related to the test supplement
5) Subjects who donated 200 mL within 1 month prior to the start of the study, or 400 mL (blood donation etc.) within 3 months
6) Smokers
7) Subjects who are judged as unsuitable for this study by physician.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Yoshio
Middle name
Last name Suzuki

Organization

Juntendo University

Division name

Graduate School of Health and Sports Science

Zip code

2701695

Address

1-1, Hiragagakuendai, Inzai, Chiba, 270-1695 Japan

TEL

+81-476-98-1001

Email

yssuzuki@juntendo.ac.jp


Public contact

Name of contact person

1st name Yoshio
Middle name
Last name Suzuki

Organization

Juntendo University

Division name

Graduate School of Health and Sports Science

Zip code

2701695

Address

1-1, Hiragagakuendai, Inzai, Chiba, 270-1695 Japan

TEL

+81-476-98-1001

Homepage URL


Email

yssuzuki@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University, Graduate School of Health and Sports Science

Institute

Department

Personal name



Funding Source

Organization

Kowa Company, Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee of Juntendo University Graduate School of Sports and Health Science

Address

1-1, Hiragagakuenndai, Inzai, Chiba 270-1695 Japan

Tel

+81476981001

Email

sc-kyomu@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学さくらキャンパス(千葉県)


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 05 Day

Date of IRB

2017 Year 09 Month 05 Day

Anticipated trial start date

2017 Year 10 Month 18 Day

Last follow-up date

2019 Year 02 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 16 Day

Last modified on

2019 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033792


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name